Overview

A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED)

Status:
Terminated
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test MK0812 on disease activity in patients with relapsing-remitting MS. Disease modifying activity will be assessed by measurement of brain lesions via MRI brain scans and an open label extension is offered.
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.